Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAP3K8 |
| Upstream (Parents) |
|---|
| (<<) ADCY7 → MAP3K8 |
| (<<) BCL2A1 → MAP3K8 |
| (<<) CABC1 → MAP3K8 |
| (<<) CSGALNACT2 → MAP3K8 |
| (<<) CXCL1 → MAP3K8 |
| (<<) CXCR7 → MAP3K8 |
| (<<) EBP → MAP3K8 |
| (<<) FZD7 → MAP3K8 |
| (<<) GLTPD1 → MAP3K8 |
| (<<) GPX4 → MAP3K8 |
| (<<) HLA-A → MAP3K8 |
| (<<) HLA-G → MAP3K8 |
| (<<) IL1B → MAP3K8 |
| (<<) ITGAV → MAP3K8 |
| (<<) JAK2 → MAP3K8 |
| (<<) JHDM1D → MAP3K8 |
| (<<) LRP5 → MAP3K8 |
| (<<) MREG → MAP3K8 |
| (<<) PTPRE → MAP3K8 |
| Downstream (Children) |
|---|
| MAP3K8 → ATP2C1 (>>) |
| MAP3K8 → BMP8B (>>) |
| MAP3K8 → CREBBP (>>) |
| MAP3K8 → EIF2AK2 (>>) |
| MAP3K8 → KLF10 (>>) |
| MAP3K8 → MAP2K2 (>>) |
| MAP3K8 → MEX3D (>>) |
| MAP3K8 → PTGS2 (>>) |
| MAP3K8 → RPS6KB1 (>>) |
| MAP3K8 → SOCS5 (>>) |
| MAP3K8 → SOX1 (>>) |
| MAP3K8 → STK11 (>>) |
